openPR Logo
Press release

Opioid Induced Side Effects Treatment Market New Business Developments And Top Companies, Future Forecasts To 2026

04-03-2019 03:25 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Opioid Induced Side Effects Treatment Market

Opioid Induced Side Effects Treatment Market

Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group.
As per stats published by National Institute on Drug Abuse (NIDA) on February 2017, despite decreased use of cocaine after 2010, deaths related to cocaine overdose increased, this increase was associated with opioids, primarily with synthetic opioids. Furthermore, according to NIDA, in 2013, the number of prescriptions for opioids was 207 million around the globe with major share accounted by North America and in 2012, around 2.1 million people in the U.S. suffering from disorders related to prescription opioid pain relievers and out of that, around 467,000 people get addicted to heroin. This fact in turn is expected to favor the growth of opioid induced side effects treatment market in the near future.

Request For a Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/387

Opioid induced side effects treatment market is expected to gain rise in market revenue in the near future on the basis of the fact that according to United Nations Office on Drugs and Crime (UNODC) in 2010, annual prevalence of opioids was around 0.6-0.8% in the people having age group 15-64 and 0.3-0.5% in the people having age more than 64 years.
Centers for Disease Control and Prevention (CDC) says that in 2015, in U.S. more than 15,000 people died because of overdose of opioids and highest overdose rate observed in the people between age group of 25-54 years. Furthermore, around 2 million people were dependent on prescription opioids in 2014 and prescription opioid receiver for noncancerous pain were 1 in 4 which takes these drugs for addiction. Also, in the U.S. every day, more than 1000 people treated in emergency department due to misuse of prescription opioids.

Opioid induced side effects treatment market taxonomy:
By Dosage Form of Drug
• Solid
• Semi-Solid
• Liquid
By Geography
• North America
• Europe
• APAC
• Latin America
• Middle East
• Africa

Increase in prevalence of chronic disease and cancer cases with raised use of prescription based opioids will favor the growth of opioid induced side effects treatment market in the near future
North America accounts for the major market share of opioid induced side effects treatment market, as U.S. is the biggest consumer for prescription based opioids. As per NIDA in 2013, out of the globe U.S. accounted around 100 percent in case of hydrocodone for example – Lortab, Norco and Vicodin, and 81% for oxycodone for example Endocet and Percocet. Also, as per American Society of Addiction Medicine (ASAM), drug overdose is the leading cause of death in U.S. and prescription opioids is the leading factor behind it. In 2015, 12,990 deaths were related with prescription based pain relievers.
The growth in opioid induced side effects treatment market is expected high in North America followed by Europe and APAC region. As per the data published by UNODC in 2012, the APAC and Africa region are the emerging markets for raw opium which could feed to increase opioid consumption and support the growth of opioid induced side effects treatment industry in near the future. Furthermore, only 20% of opioid users received treatment against their drug dependence and treatment demand is growing in Asia and Europe region. The South America has shown negligible growth in demand for treatment against opioid drug dependency.

Some of the key players in the global opioid induced side effects treatment market are Shionogi & Co., Ltd., Cubist Pharmaceuticals, Inc., AIKO Biotechnology, Inc., SLA Pharma AG, Progenics Pharmaceuticals Inc. and AstraZeneca plc.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/387

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr.Shah
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opioid Induced Side Effects Treatment Market New Business Developments And Top Companies, Future Forecasts To 2026 here

News-ID: 1686232 • Views:

More Releases from Coherent Market Insights

Anticoagulant Market is Going to Booming Growth 2026 With Top Key Players Analysis Through 2023|Pfizer Inc., Sanofi SA, Dr. Reddys Laboratories, Aspen Holdings
Anticoagulant Market is Going to Booming Growth 2026 With Top Key Players Analys …
The latest report by Coherent Market Insights indicates strong growth potential for the Anticoagulant Market from 2026 to 2033, supported by rising industry demand, expanding applications, and ongoing technological advancements. The study delivers a clear overview of market size, revenue trends, and key growth factors shaping the global landscape. This research analyzes major market drivers, restraints, challenges, and emerging opportunities, while highlighting innovation trends and financial insights influencing competitive strategies.
Heparin Calcium Market Is Going to Boom Rapidly With Top Key Players Sanofi, Pfizer Inc., Dongying Tiandong Pharmaceutical Co., Ltd.
Heparin Calcium Market Is Going to Boom Rapidly With Top Key Players Sanofi, Pfi …
Heparin Calcium Market is estimated to be valued at USD 1,485.0 Mn in 2025 and is expected to reach USD 1,789.4 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 2.7% from 2025 to 2032. The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Heparin Calcium Market. From 2026 to 2033, this
Betamethasone Acetate Market Strategic Outlook 2026-2033: Navigating Competitive Disruption and Long-Term Value |Merck & Co., Inc., American Regent, Inc.
Betamethasone Acetate Market Strategic Outlook 2026-2033: Navigating Competitive …
Betamethasone Acetate Market is estimated to be valued at USD 484.6 Mn in 2025 and is expected to reach USD 672.8 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2025 to 2032. The latest report by Coherent Market Insights indicates strong growth potential for the Betamethasone Acetate Market from 2026 to 2033, supported by rising industry demand, expanding applications, and ongoing technological advancements. The study delivers
Diphtheria Vaccine Market Size, Share, Trends, Competitive Landscape, Regional Analysis Forecasts By 2023 |AJ Vaccines A/S., BIONET-ASIA, GlaxoSmithKline plc., MassBiologics
Diphtheria Vaccine Market Size, Share, Trends, Competitive Landscape, Regional A …
Diphtheria Vaccine Market is estimated to be valued at USD 6,047.7 Mn in 2025 and is expected to reach USD 9,009.8 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.86% from 2025 to 2032. The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Diphtheria Vaccine Market. From 2026 to 2033,

All 5 Releases


More Releases for Opioid

Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Opioid-Induced Constipation Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for treatment of opioid-induced constipation has seen a substantial growth recently. It is expected to escalate from a solid $1.78 billion in 2024 to an impressive $1.9 billion in 2025, exhibiting
Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Opioid Use Disorder (OUD) Market Size By 2025? The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound
Key Influencer in the Opioid-Induced Constipation Treatment Market 2025: Rising …
What combination of drivers is leading to accelerated growth in the opioid-induced constipation treatment market? The rise in opioid administration for cancer and non-cancer pain is expected to drive the growth of the opioid-induced constipation (OIC) treatment market. Opioids are commonly used for managing moderate to severe pain, but they can cause constipation. OIC treatments are vital for improving the quality of life for patients on opioids, allowing them to maintain
Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Numb …
How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market? The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance
What's Driving the Opioid-Induced Constipation Treatment Market 2025-2034: Risin …
What Are the Projections for the Size and Growth Rate of the Opioid-Induced Constipation Treatment Market? The market size for treatments of constipation caused by opioids has seen robust growth lately. The forecasted growth indicates an increase from $1.78 billion in 2024 to $1.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%. This past growth is associated with a growing elderly population, individualized treatments for OIC, the
MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana. Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622 Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal